Retatrutide 10 mg is a next-generation peptide innovation acting as a triple receptor agonist (GLP-1, GIP, and Glucagon). Designed for maximum efficiency in weight management, appetite control, and metabolic acceleration, Retatrutide sets a new benchmark in targeted body weight reduction. The kit includes sterile water for reconstituting the solution.

Indications: Retatrutide 10 mg is used for:

• Effective body weight reduction in obesity and overweight management

• Potent appetite suppression and reduction of food cravings

• Enhancing insulin sensitivity and supporting healthy blood glucose control

• Accelerating basal metabolic rate and daily energy expenditure

Reasons for Use:

• Need for significant and sustained weight loss

• Difficulty managing overeating or persistent appetite

• Metabolic syndrome and reduced tissue sensitivity to insulin

• Reaching a weight-loss plateau with previous-generation therapies (Semaglutide, Tirzepatide)

Key Features:

• Triple action mechanism targeting GLP-1, GIP, and Glucagon receptors

• Enhanced subcutaneous and visceral fat breakdown driven by the glucagon component

• Delays gastric emptying to maintain prolonged satiety after meals

• Complete kit format: includes diluent (water for injection) for easy mixing

• Improves systemic metabolic profile and supports healthy lipid levels

Dosage Form: Retatrutide — Injection Kit: 10 mg lyophilized powder vial + diluent (sterile water for reconstitution)

Manufacturer: PharmaSol

Active Ingredients:

• Retatrutide — 10 mg

• Diluent (Sterile Water for Injection)

#Retatrutide #PharmaSol #WeightLoss #TripleAgonist #GLP1 #GIP #Glucagon #AppetiteControl #Metabolism #IsraeliMeds #PharmacyIsrael